Why to use URIVAC?

One of the methods to enhance general immune defence of the organism and of the urinary tract is modulation of the immune mechanisms using URIVAC.

Acute and chronic urinary bladder infection, infection of urethra, urethers and kidney pelvis could be a separate disease or could be associated with other diseases. These could be manifested as mild and subside without any consequences or could result in damage to the kidney tissue (parenchyma) and serious impairment of function and renal failure.

The cause of urinary tract infection is the presence of harmful bacteria in the urinary tracts. The most frequent bacteria to the urinary tract pass against the flow of urine - from urethra to the urinary bladder. If the urinary bladder is not sufficiently flushed with regular intake of fluids, bacteria in the urinary bladder are rapidly propagating. From there, there is only a small step to a more serious inflammation of the kidneys.

Development of urinary tract infections is influenced by various predisposition factors (anatomical and physiological differences related to gender with more frequent occurrence in women, pregnancy, urinary tract obstructions or impaired outflow of urine, inflammatory lesions in the surrounding area, disorders of metabolism, etc.).

Urinary tract infection affects every other woman at least once in a life. Complaints subside spontaneously or antibiotics may help. If the inflammation recurs, the cause may be an impaired immunity.

One of the methods to enhance general immune defence of the organism and of the urinary tract is modulation of the immune mechanisms using URIVAC. URIVAC is a patented product developed in cooperation with specialists from the Medical Faculty of the Palacky University in Olomouc.

It contains harmless parts of bacteria, which are frequently responsible for urinary tract infections and which stimulate immunity and thereby support the natural defence of the organism.

References: Koukalová D., Hájek V., Koďousek R. Vývoj vakcíny pro léčbu zánětlivých onemocnění močových cest. Bratislavské lékařské listy100, 1999, 92-95.
Koukalová D., Kročová Z., Vítek P., Macela A., Hájek V. Imunostimulační aktivita vakcíny pro léčbu recidivujících uroinfekcí. I. Bratislavské lékařské listy 100, 1999, 215-217.

 

URIVAC is produced with the most up-to-date biotechnological and purification technologies. It contains a unique combination of purified lysates (highly purified harmless parts of inactivated microorganisms) from six original patented bacterial strains, which are most frequently contributing on the development of urological inflammation.

URIVAC positively influences the immune system and helps to increase defence of the organism, mainly of vaginal mucosa. 

The application form of the preparation is an oral capsule. One pack of URIVAC contains 30 capsules, which are used orally within a three-month treatment. URIVAC is an over-the-counter drug available in pharmacies.

 

URIVAC . . . for healthy urinary tracts

Original patented immunomodulation product

Support of the immune system of the organism, especially of the urinary tract

  

• URIVAC has a positive effect on the immune system
• URIVAC supports the defence system of the organism, especially of the urinary tract
• URIVAC is used in men and women to enhance non-specific immunity
• URIVAC contains a dose for three months in one packaging
• URIVAC is used once daily
• URIVAC is available over-the-counter
• URIVAC is not intended as a supplement of rich diet

 

Read the package insert before use carefully. You can get more information about the food supplement on the address  SD PharmaCZ, spol. s r.o., Písnická  22,  142 00 Prague 4, tel.: +420 296 303 370